YH4808 30mg + YH4808 50mg + YH4808 100mg + YH4808 200mg + YH4808 + YH4808 100mg (repeat dose) + YH4808 200mg (repeat dose) + YH4808 600mg + YH4808 800mg (single dose) + YH4808 400 mg (repeat doses) + Placebo + Esomeprazole 40mg
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Healthy
Conditions
Healthy
Trial Timeline
Nov 1, 2009 → Mar 1, 2012
NCT ID
NCT01007019About YH4808 30mg + YH4808 50mg + YH4808 100mg + YH4808 200mg + YH4808 + YH4808 100mg (repeat dose) + YH4808 200mg (repeat dose) + YH4808 600mg + YH4808 800mg (single dose) + YH4808 400 mg (repeat doses) + Placebo + Esomeprazole 40mg
YH4808 30mg + YH4808 50mg + YH4808 100mg + YH4808 200mg + YH4808 + YH4808 100mg (repeat dose) + YH4808 200mg (repeat dose) + YH4808 600mg + YH4808 800mg (single dose) + YH4808 400 mg (repeat doses) + Placebo + Esomeprazole 40mg is a phase 1 stage product being developed by Yuhan for Healthy. The current trial status is completed. This product is registered under clinical trial identifier NCT01007019. Target conditions include Healthy.
What happened to similar drugs?
20 of 20 similar drugs in Healthy were approved
Approved (20) Terminated (1) Active (0)
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01007019 | Phase 1 | Completed |
Competing Products
20 competing products in Healthy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Use of Wearable Digital Sensors After mRNA Vaccination in Adults | Moderna | Preclinical | 0 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| mRNA-6231 | Moderna | Phase 1 | 0 |
| Letrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Isotretinoin | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Fexofenadine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sertraline | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Nizatidine + Axid | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Anastrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-1273.712 | Moderna | Approved | 0 |
| Risperidone | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Metformin + Glucophage | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| Divalproex Sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sirolimus | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Glimepiride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Ziprasidone Hydrochloride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Naproxen sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |